Accelerating Medical Treatments for Serious Mental Illness (Trump EO Tracker)

This Executive Order instructs federal agencies to accelerate research, review, and potential approval pathways for psychedelic drugs intended to treat serious mental illnesses, including major depressive disorder and substance abuse disorder. The EO directs FDA to prioritize review of qualifying products with Breakthrough Therapy designation through the National Priority Voucher Program and to facilitate access…... By: Akin Gump Strauss Hauer & Feld LLP